Watch Ticker

Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock

Go to Fortress Biotech, Inc. 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock Website

$7.25

0.00 (0.00%)

Live

Previous Close

$7.25

Day Range

$0 - $0

Previous Day Range

$7 - $7.25

Market Cap

$ USD

Day Vol.

Previous Day Vol.

15671

Currency

USD

Primary Exchange

Nasdaq

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Tar...

Community

0 posts discussing

0

Watchers

1

Visitors

Recent News

Globe Newswire - Fortress Biotech Announces Closing of Sale of Subsidiary Checkpoint Therapeutics

Fortress Biotech announced the closing of the sale of its subsidiary Checkpoint Therapeutics to Sun Pharmaceutical Industries Limited. The transaction will generate approximately $28 million for Fortress and a 2.5% royalty on net sales of Checkpoint's FDA-approved drug UNLOXCYT.

Related tickers: FBIO, FBIOP, CKPT.

Read Full Article

N/A - Fortress Biotech to Participate in the H.C. Wainwright 1st Annual Royalty Company Virtual Conference

Fortress Biotech, an innovative biopharmaceutical company, announced the FDA approval of its drug Emrosi for the treatment of inflammatory lesions of rosacea in adults, with commercial launch underway. The company also announced a strategic collaboration with Partex NV to accelerate asset identification and evaluation using Partex's proprietary AI platform.

Related tickers: FBIO, FBIOP.

Read Full Article

Trending Tickers

Please sign in to view